Stock Track | Hinge Health Soars 9.15% in Pre-Market on Strong Q1 Earnings Beat and Raised 2026 Guidance

Stock Track05-06

Hinge Health, Inc. (HNGE) experienced a significant pre-market surge of 9.15% on Wednesday, following the release of its first-quarter 2026 financial results which significantly exceeded analyst expectations.

The digital health company reported revenue of $182.3 million, a 47% year-over-year increase that beat the consensus estimate of $172.2 million. Adjusted earnings per share came in at $0.45, surpassing the expected $0.38-$0.40 range. Management also raised its full-year 2026 revenue outlook to $798 million-$804 million, up substantially from prior guidance of $732 million-$742 million.

The strong results prompted multiple analyst upgrades, with Canaccord Genuity raising its price target to $63 from $53 and RBC increasing its target to $65 from $55. The company's expansion into new care categories and profitable growth trajectory were highlighted as key drivers for the positive market reaction.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment